Cardioprotective potential of oleuropein, hydroxytyrosol, oleocanthal and their combination: Unravelling complementary effects on acute myocardial infarction and metabolic syndrome-Reference-Cited by-同舟云学术

Cardioprotective potential of oleuropein, hydroxytyrosol, oleocanthal and their combination: Unravelling complementary effects on acute myocardial infarction and metabolic syndrome

Published:2024-10 Issue: Volume:76 Page:103311
ISSN:2213-2317
Container-title:Redox Biology
language:en
Short-container-title:Redox Biology

Author:

Christodoulou Andriana,Nikolaou Panagiota-Efstathia,Symeonidi Lydia,Katogiannis Konstantinos,Pechlivani Louisa,Nikou Theodora,Varela Aimilia,Chania Christina,Zerikiotis Stelios,Efentakis Panagiotis,Vlachodimitropoulos Dimitris,Katsoulas Nikolaos,Agapaki Anna,Dimitriou Costantinos,Tsoumani Maria,Kostomitsopoulos Nikolaos,Davos Constantinos H.,Skaltsounis Alexios Leandros,Tselepis Alexandros,Halabalaki Maria,Tseti Ioulia,Iliodromitis Efstathios K.,Ikonomidis Ignatios,Andreadou Ioanna

Funder

Hellenic Atherosclerosis Society

General Secretariat for Research and Technology

GW Research

Create NSW

National College Students Innovation and Entrepreneurship Training Program

Publisher

Elsevier BV

Reference102 articles.

1. Mortality from ischemic heart disease;Nowbar;Circ. Cardiovasc. Qual. Outcomes,2019

2. Definition of metabolic syndrome;Grundy;Circulation,2004

3. Cardiovascular morbidity and mortality associated with the metabolic syndrome;Isomaa;Diabetes Care,2001

4. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

5. Interaction of cardiovascular nonmodifiable risk factors, comorbidities and comedications with ischemia/reperfusion injury and cardioprotection by pharmacological treatments and ischemic conditioning;Ferdinandy;Pharmacol. Rev.,2023